Australian Stem Cell Research Forges Ahead

Main Category: Stem Cell Research
Article Date: 20 Jun 2008 - 5:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Australian stem cell scientists will build on the recent discovery that stem cells can be made from skin cells in a new collaborative research program, Victorian Innovation Minister Gavin Jennings and NSW Minister for Science and Medical Research Verity Firth announced at the BIO International Convention.

The Australian scientists will spearhead a program to compare cells generated from skin cells, known as induced pluripotent stem (iPS) cells, with human embryo derived stem cells and stem cells derived from a somatic cell nuclear transfer (SCNT) process using clinically unusable eggs, in a bid to develop a routine repeatable way of making patient-specific stem cells within the nationally approved legislative guidelines.

Sydney IVF Limited and the Australian Stem Cell Centre have received $550,000 from the NSW and Victorian Governments to progress this new frontier of stem cell research.

This pioneering work has only become possible due to the new funding and recent changes to legislation in both Victoria and NSW, opening up opportunities for SCNT research to occur in Australia.

SCNT uses a patient's own cells to create a source of individually tailored embryonic stem cells. For patients with a specific disease these stem cells will have unique characteristics that may be used to better understand and treat the disease process.

"This important initiative will put Australian scientists yet again at the forefront of stem cell research," said Mr. Jennings.

"The promise of pluripotent stem cells is vast because they have the potential to develop into specialised cells that could be used as replacement cells and tissues to treat many diseases and conditions, help us to understand what causes birth defects and cancer and change the way we develop and test drugs," Mr. Jennings said.

Scientists from Japan and America made the discovery that stem cell-like cells could be made from human skin cells in late 2007.

Sydney IVF, one of Australia's premier assisted reproduction facilities, will undertake the SCNT work in this program. Since 2004, Sydney IVF has obtained five National Health and Medical Research Council embryo research licenses and produced over 20 human embryonic stem cell lines.

The Australian Stem Cell Centre, the Biotechnology Centre of Excellence based in Melbourne, will perform the characterisation and comparison of the stem cell-like cells.

"The combination of the international quality talent and significant resources of these two collaborative partners gives this project the potential to provide world first advancements in these new biological frontiers," said Ms. Firth.

Recent US research has turned embryonic stem cells into insulin producing cells in mice, representing a possible cure for type 1 diabetes and there is already proof of concept that stem cells can restore function to damaged tissues in models of Parkinson's disease and immuno-deficiency.

Victoria and NSW have led the way nationally in stem cell research and are already global leaders in the field.

"Victoria and NSW have now come together to extend our leadership into new stem cell technologies which have the potential to transform how we treat major and growing diseases like diabetes, heart disease, cancer and Parkinson's," the Ministers said.

The amended Victorian Infertility Treatment Act and the NSW Human Cloning and Other Prohibited Practices Act were introduced in 2007 and provide a clear regulatory framework for stem cell research.

http://www.bio.org